FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317495513> ?p ?o ?g. }

• W4317495513 abstract "Abstract Refractory lupus nephritis (RLN) is a clinical condition with high risk of a poor outcome and often life-threatening. Six patients (one male and 5 females), aged 41.3 years (range 20 to 61 years) were treated with Daratumumab monotherapy, a monoclonal antibody targeting CD38 which is highly expressed on the surface of many immune cells, especially plasma cells. The treatment protocol consisted of 16 mg/kg daratumumab administered intravenously weekly for 8 weeks, then every two weeks 8 more times, and lastly monthly (maximum 8 infusions). All patients failed previous treatments with the Standard of Care (SOC) including mycophenolate mofetil (MMF), cyclophosphamide (CYC), azathioprine and rescue therapies including Rituximab (RTX), Ocrelizumab, Belimumab, and iv IgG. One out of six patients did not show clinical response after 6 months of therapy, and Daratumumab was discontinued. Five patients showing a clinical response over the same period continued to be treated and reached a 12-month observation. Renal biopsy performed before daratumumab administration revealed a class IV LN in 1 patient, class V LN in 1 patient, class III + V LN in 1 patient and class IV + V LN in the other 2. Three patients achieved a complete renal response and the other two a partial renal response. A significant decrease in proteinuria from 5.6 gr/24 hours to 0.8 g/24 hours (p = 0.001) was achieved at 12 months. The mean value of serum Creatinine (sCr) decreased from 2.3 to 1.5 mg/dl. Improvement of clinical symptoms was paralleled by seroconversion of anti-double-stranded DNA antibodies (p = 0.03), significant decrease in interferon-gamma values (p = 0.0006), BMCA-B-cell maturation antigen (p = 0.0005) and soluble CD163 levels (p = 0.045), and increase in C4 (p = 0.018) and IL 10 levels (p = 0.0006). Clinical remission was substantiated by improvement of SLEDAI-2K score (p = 0.03). Daratumumab was generally well tolerated. These data suggest that Daratumumab administered alone (i.e., without any other immunosuppressant or agents targeting B-cell activating factor) is highly effective in RLN." @default.
• W4317495513 created "2023-01-20" @default.
• W4317495513 creator A5012705049 @default.
• W4317495513 creator A5014323438 @default.
• W4317495513 creator A5017039749 @default.
• W4317495513 creator A5018627411 @default.
• W4317495513 creator A5036828463 @default.
• W4317495513 creator A5043758235 @default.
• W4317495513 creator A5048345840 @default.
• W4317495513 creator A5052838173 @default.
• W4317495513 creator A5058973250 @default.
• W4317495513 creator A5074577325 @default.
• W4317495513 creator A5084799650 @default.
• W4317495513 creator A5086035399 @default.
• W4317495513 date "2023-01-19" @default.
• W4317495513 modified "2023-09-30" @default.
• W4317495513 title "Daratumumab monotherapy for refractory lupus nephritis" @default.
• W4317495513 cites W1963756694 @default.
• W4317495513 cites W1976026635 @default.
• W4317495513 cites W1976803657 @default.
• W4317495513 cites W1979972981 @default.
• W4317495513 cites W1983015423 @default.
• W4317495513 cites W1995495045 @default.
• W4317495513 cites W2007518616 @default.
• W4317495513 cites W2099928036 @default.
• W4317495513 cites W2106273198 @default.
• W4317495513 cites W2112275671 @default.
• W4317495513 cites W2131457901 @default.
• W4317495513 cites W2135950058 @default.
• W4317495513 cites W2138437964 @default.
• W4317495513 cites W2157519867 @default.
• W4317495513 cites W2168888135 @default.
• W4317495513 cites W2192587622 @default.
• W4317495513 cites W2214694678 @default.
• W4317495513 cites W2486559230 @default.
• W4317495513 cites W2741174708 @default.
• W4317495513 cites W2921255794 @default.
• W4317495513 cites W2927871970 @default.
• W4317495513 cites W2956187959 @default.
• W4317495513 cites W2967918238 @default.
• W4317495513 cites W2974540671 @default.
• W4317495513 cites W2981100201 @default.
• W4317495513 cites W3015877373 @default.
• W4317495513 cites W3034340360 @default.
• W4317495513 cites W3086471819 @default.
• W4317495513 cites W3128714093 @default.
• W4317495513 cites W3134697946 @default.
• W4317495513 cites W3162675161 @default.
• W4317495513 cites W3199695429 @default.
• W4317495513 cites W3202510981 @default.
• W4317495513 cites W3204486592 @default.
• W4317495513 cites W4210593746 @default.
• W4317495513 cites W4212961301 @default.
• W4317495513 cites W4286646652 @default.
• W4317495513 cites W4318931693 @default.
• W4317495513 doi "https://doi.org/10.21203/rs.3.rs-2472742/v1" @default.
• W4317495513 hasPublicationYear "2023" @default.
• W4317495513 type Work @default.
• W4317495513 citedByCount "0" @default.
• W4317495513 crossrefType "posted-content" @default.
• W4317495513 hasAuthorship W4317495513A5012705049 @default.
• W4317495513 hasAuthorship W4317495513A5014323438 @default.
• W4317495513 hasAuthorship W4317495513A5017039749 @default.
• W4317495513 hasAuthorship W4317495513A5018627411 @default.
• W4317495513 hasAuthorship W4317495513A5036828463 @default.
• W4317495513 hasAuthorship W4317495513A5043758235 @default.
• W4317495513 hasAuthorship W4317495513A5048345840 @default.
• W4317495513 hasAuthorship W4317495513A5052838173 @default.
• W4317495513 hasAuthorship W4317495513A5058973250 @default.
• W4317495513 hasAuthorship W4317495513A5074577325 @default.
• W4317495513 hasAuthorship W4317495513A5084799650 @default.
• W4317495513 hasAuthorship W4317495513A5086035399 @default.
• W4317495513 hasBestOaLocation W43174955131 @default.
• W4317495513 hasConcept C126322002 @default.
• W4317495513 hasConcept C126894567 @default.
• W4317495513 hasConcept C141071460 @default.
• W4317495513 hasConcept C2776063141 @default.
• W4317495513 hasConcept C2779134260 @default.
• W4317495513 hasConcept C2779338263 @default.
• W4317495513 hasConcept C2779561371 @default.
• W4317495513 hasConcept C2779912601 @default.
• W4317495513 hasConcept C2780091579 @default.
• W4317495513 hasConcept C2780306776 @default.
• W4317495513 hasConcept C2780401358 @default.
• W4317495513 hasConcept C2780653079 @default.
• W4317495513 hasConcept C2781119759 @default.
• W4317495513 hasConcept C71924100 @default.
• W4317495513 hasConcept C90924648 @default.
• W4317495513 hasConceptScore W4317495513C126322002 @default.
• W4317495513 hasConceptScore W4317495513C126894567 @default.
• W4317495513 hasConceptScore W4317495513C141071460 @default.
• W4317495513 hasConceptScore W4317495513C2776063141 @default.
• W4317495513 hasConceptScore W4317495513C2779134260 @default.
• W4317495513 hasConceptScore W4317495513C2779338263 @default.
• W4317495513 hasConceptScore W4317495513C2779561371 @default.
• W4317495513 hasConceptScore W4317495513C2779912601 @default.
• W4317495513 hasConceptScore W4317495513C2780091579 @default.
• W4317495513 hasConceptScore W4317495513C2780306776 @default.
• W4317495513 hasConceptScore W4317495513C2780401358 @default.
• W4317495513 hasConceptScore W4317495513C2780653079 @default.

• next